Complete response to bevacizumab plus irinotecan in patients with rapidly progressive GBM: Cases report and literature reviewOguz Ozel a , Mehmet Kurt b , Oguzhan Ozdemir c , Jale Bayram b , Huseyin Akdeniz b , Dogan Koca d,a Van Speciality Istanbul Hospital, Department of Neurosurgical Oncology, 65001, Van, Turkey
b Van Speciality Istanbul Hospital, Department of Radiology, 65001, Van, Turkey
c Recep Tayyip Erdogan University, Department of Radiology, 53100, Rize, Turkey
d Van Speciality Istanbul Hospital, Department of Internal Diseases, Division of Medical Oncology, 65001, Van, TurkeyDOI: https://doi.org/10.1016/j.jons.2016.07.009 Sayfalar: 87 - 94 862 Viewed.
The Real-Life Efficacy of the Second Line Treatment Strategy in Advanced Pancreas CancerMutlu HIZALa, Mehmet Ali Nahit ŞENDURb, Burak BİLGİNb, Ebru KARCI GÜNERc,
Muhammed Bülent AKINCIb, Yakup ERGÜNa, Ece ESİNd, Elif Berna KÖKSOYe,
Ahmet SEZERf, Nuriye ÖZDEMİRg, Berna ÖKSÜZOĞLUd, Bülent YALÇINb,
Güngör UTKANe, Yüksel ÜRÜNeaClinic of Medical Oncology, Ankara City Hospital, Ankara, Türkiye
bDivision of Medical Oncology, Ankara Yıldırım Beyazıt University Faculty of Medicine, Ankara, Türkiye
cDivision of Medical Oncology, Medipol University Faculty of Medicine, İstanbul, Türkiye
dDivision of Medical Oncology, University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Health Application and Research Center, Ankara, Türkiye
eDivision of Medical Oncology, Ankara University Faculty of Medicine, Ankara, Türkiye
fDivision of Medical Oncology, Başkent University Faculty of Medicine, Adana, Türkiye
gDivision of Medical Oncology, Gazi University Faculty of Medicine, Ankara, TürkiyeDOI: 10.37047/jos.2022-88853 Sayfalar: 69 - 75 326 Viewed.